학술논문
Qualitative research influencing guideline and policy: An exemplar of the development of a national school asthma guideline in Malaysia.
Document Type
Academic Journal
Author
Ramdzan SN; Department of Primary Care Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.; Khoo EM; Department of Primary Care Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.; Cunningham S; NIHR Global Health Research Unit of Respiratory Health (RESPIRE), Usher Institute, The University of Edinburgh, UK.; Hussein N; Department of Primary Care Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.; Ramli R; Department of Primary Care Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.; Senawi SA; Sektor Pengurusan Pembelajaran, Bahagian Pengurusan Sekolah Harian, Ministry of Education, Putrajaya, Malaysia.; Sukri N; Department of Primary Care Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.; Nathan JJ; Department of Primary Care Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.; Kassim A; Paediatric Department, Hospital Tunku Azizah Kuala Lumpur, Malaysia.; Ahad AM; Port Dickson Health Clinic, Ministry of Health, Malaysia.; Pinnock H; NIHR Global Health Research Unit of Respiratory Health (RESPIRE), Usher Institute, The University of Edinburgh, UK.
Source
Publisher: International Society of Global Health Country of Publication: Scotland NLM ID: 101578780 Publication Model: Electronic Cited Medium: Internet ISSN: 2047-2986 (Electronic) Linking ISSN: 20472978 NLM ISO Abbreviation: J Glob Health Subsets: MEDLINE
Subject
Language
English
Abstract
Competing Interests: Disclosure of interest: The authors completed the ICMJE Disclosure of Interest Form (available upon request from the corresponding author) and declare the following activities and relationships: EMK reports grants from the National Institute for Health Research Global Health Research Unit on Respiratory Health (RESPIRE); personal fees from AstraZeneca; and is the President of the International Primary Care Respiratory Group and the Primary Care Respiratory Group Malaysia. HP reports speaker fees from Teva and Sandoz Pharmaceutical for non-promotional talks. All other authors declare no relevant interests.